Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Initiative Updates
-
Hi,
Are there any updates on the Creative Imagery guidance? As we are ramping up our efforts to integrate GenAI in our creative exercises, a guidance PDF would come in handy.
Thanks in advance!
PaulHey @costeap
We are working on cleaning up a final draft document that will help to provide additional guardrails when developing creative. We hope to have this draft back in front of the committee by the end of the month and posted shortly there after Note that PAAB guidance documents are not permitted to be integrated into training material for AI per the following disclaimer on our website and the forum:
“The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited.”
